A therapy can clear its trials and still stall on the plant floor. The reasons are rarely scientific. They are usually about who is in the building, who owns which decision, and whether the people who understand the process are still around when production grows.
If you run operations, quality or manufacturing at a life sciences company in Canada or the US, the move from clinical supply to commercial production is a hiring problem as much as an engineering one. Here is how we would plan it.
The roles change faster than the org chart
During development, the team leans on clinical operations, data management, regulatory strategy and medical writing. Commercial production needs a different mix:
- Validation engineers
- Quality assurance specialists and quality control analysts
- Manufacturing associates and operators
- Automation and controls technicians
- Supply chain and production planners
- Computer system validation specialists
- Regulatory CMC support
- Project managers who can hold a launch plan together
Most of these people are not interchangeable. A validation engineer who has worked under GMP is not the same hire as a general process engineer, and the gap shows up during the first inspection.
Where launches slip
In our experience the delays cluster in a few places:
- Manufacturing joins the conversation late, after the process is already fixed.
- Knowledge sits with a few people and does not make it into batch records, method documents or deviation history.
- Validation schedules are built on the launch date, not on how many qualified people are available.
- Quality is asked to review at the end instead of shaping the transfer.
- Inspection preparation starts a few weeks out.
- Demand forecasts are never matched against validated capacity or staffing.
Every item on that list can be seen 12 to 18 months ahead. That is the window to hire in.
Hire for the transfer, not just the launch
Tech transfer is where detail gets lost. The receiving team needs the critical process parameters, quality attributes, equipment requirements, supplier information and the history of what went wrong in clinical manufacturing. That only works if the right people are in seat early enough to absorb it.
Two practical moves help:
- Bring in your commercial manufacturing lead and a senior quality person before the clinical phase ends, so they sit in on the process decisions rather than inherit them.
- Keep at least one person from the development side attached to the process through qualification. Handing off and walking away is how sensitivities get forgotten.
Regulators in both countries expect process validation to run across the product lifecycle, from design through commercial production. That is a strong argument for continuity of staff, not a one-time team assembled for a single check.
Treat quality as a hiring priority
Documentation, deviation handling, CAPA, change control, supplier qualification and training all have to scale with volume. A quality group sized for clinical batches will be overrun by commercial ones.
Before launch, ask:
- Who owns quality decisions during transfer, by name?
- Can the deviation and CAPA process handle several times today's volume?
- Are operators trained and documented as qualified, not just experienced?
- Do we have enough quality headcount to support validation and a pre-approval inspection at the same time?
If the answer to any of these is a hope rather than a name, that is an open requisition.
Permanent, contract or both
Your internal people are already stretched by trials, submissions and launch planning. Hiring permanent staff for every surge rarely makes sense, and leaving critical functions thin costs more than the contract rate.
A workable split:
| Need | Usually best as |
|---|---|
| Quality leadership, manufacturing management, process owners | Permanent |
| Validation, CSV and commissioning projects | Contract |
| Operators and manufacturing associates for ramp-up | Contract-to-hire |
| Inspection readiness and remediation support | Short-term contract |
Contract-to-hire is worth special mention for operators and technicians. It lets you see who holds up in a GMP environment before you commit, and it gives strong people a clear path onto your payroll once volume is steady.
Connect the data, but keep it practical
Siloed spreadsheets across clinical, quality and manufacturing make risks hard to see. Better visibility into batch performance, validation status, supplier risk and quality events helps, but the systems have to meet data integrity and audit trail expectations. That means people who understand both the technology and the regulated environment, which is a narrow talent pool. Plan for it early, especially if you are bringing in automation or data specialists.
Match capacity to demand, including people
Capacity planning usually focuses on equipment and suppliers. Add headcount to the same model. If demand could outpace validated capacity, it can just as easily outpace the number of trained shift operators and quality reviewers you have. Shift coverage, qualification time and lead time to hire all belong on the launch timeline.
What to do next
Take your launch date and work backward. List every role the commercial process needs, mark which are filled by someone qualified today, and put a hiring date next to each gap, allowing for notice periods, relocation and training. Anything that has to start in the next 6 months should be moving now.
A Traverse recruiter can help you find permanent and contract operations, quality and manufacturing people for that plan.